Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

1.09
 
USD
  
-0.04
  
(-3.54%)
Optionable: Yes  Market Cap: 127 M  90-day average vol: 1,799,678

Previous close: 1.13  Open: 1.12  Bid: 1.1  Ask: 1.12
52 week range    
0.62   
   4.09
Peers   
MRK / 
BMY / 
ABT / 
Last updated: Wednesday 24th April 2024
40
MarketXLS Rank
40
Value
30
Technical
50
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABT

0.0147225 B32.4128.05

BMY

0.0332145 B-27.366.19

EXEL

6 B35.119.1

MRK

0.0356207 B28.877.58
Financials

KPTI Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-1.65-2.02-1.25
Basic EPS total-1.65-2.02-1.25
Basic weighted shares outstanding31 M36 M38 M46 M57 M62 M72044.075 M82 M114 M
Cost of sales-300000.03 M5 M5 M
Depreciation1000000.01000000.0789000.0621000.0
Depreciation unreconciled-323000.0-634000.0-717000.0-713000.0-700000.0-1000000.0
DepreciationAndAmortization-323000.0-634000.0-717000.0-713000.0-700000.01000000.01000000.0789000.0621000.0
Diluted EPS total-2.43-3.32-2.92-2.81-3.14-3.22-2.72-1.65-2.02-1.25
Diluted normalized net income/share-3.14-3.22-2.72-2.02-1.25
Diluted weighted shares outstanding31 M36 M38 M46 M57 M62 M72044.075 M82 M114 M
GainOnSaleOfSecurity500000.090000.0
GeneralAndAdministrativeExpense16 M22 M24 M25 M49 M105 M126 M144 M145 M132 M
Gross operating profit229000.0250000.0154000.02 M30 M41 M108 M206 M152 M141 M
Income before tax-76 M-118 M-109 M-129 M-178 M-200 M-196 M-124 M-165 M-143 M
Income taxes139000.063000.026000.040000.0309000.0268000.0369000.0323000.0
Interest income97000.0897000.01 M2 M4 M5 M3 M582000.02 M11 M
InterestExpenseNonOperating1000.02 M16 M27 M26 M25 M24 M
MiscOtherSpecialCharges-27000.0-2000.010000.0-81000.0-33000.0-50000.0206000.0-85000.0-83000.0-356000.0
Net income from total operations-76 M-118 M-110 M-129 M-178 M-200 M-196 M-124 M-165 M-143 M
NetIncomeCommonStockholders-76 M-118 M-110 M-129 M-178 M-200 M-196 M-124 M-165 M-143 M
NetIncomeContinuousOperations-76 M-118 M-110 M-129 M-178 M-200 M-196 M-124 M-165 M-143 M
NetNonOperatingInterestIncomeExpense96000.0897000.01 M2 M2 M-10 M-24 M-25 M-23 M-13 M
Operating income-76 M-119 M-111 M-131 M-180 M-189 M-172 M-98 M-142 M-130 M
Operating income before depreciation (EBITDA)-75 M-116 M-108 M-127 M-174 M-177 M-158 M-95 M-139 M-122 M
OperatingExpense-76 M-119 M-111 M-132 M210 M230 M280 M308 M299 M276 M
Other income net27000.02000.0-10000.081000.033000.050000.0-206000.085000.083000.0356000.0
OtherGandA16 M22 M24 M25 M49 M105 M126 M144 M145 M132 M
OtherOperatingExpenses-76 M-119 M-111 M-132 M-210 M2 M3 M3 M3 M3 M
RentAndLandingFees16 M22 M24 M25 M-2 M
Research & development expense60 M98 M87 M107 M161 M122 M151 M161 M149 M139 M
ResearchExpense60 M98 M87 M107 M161 M122 M151 M161 M149 M139 M
SalariesAndWages-14 M-17 M-22 M-20 M-17 M2 M3 M30 M35 M22 M
Selling Gen & administrative expense16 M22 M24 M25 M49 M105 M126 M144 M145 M132 M
SellingAndMarketingExpense49 M105 M126 M
SellingExpense49 M105 M126 M
Total Income available for interest expense (EBIT)-76 M-118 M-109 M-129 M-176 M-184 M-169 M-98 M-140 M-119 M
Total common shares outstanding36 M36 M42 M50 M61 M66 M75 M79 M113 M115 M
Total net income-76 M-118 M-110 M-129 M-178 M-200 M-196 M-124 M-165 M-143 M
Total ordinary shares115 M115 M115 M115 M115 M115 M115 M115 M115 M115 M
Total revenues229000.0250000.0154000.02 M30 M41 M108 M210 M157 M146 M
TotalExpenses-76 M-119 M-111 M-132 M210 M230 M280 M311 M304 M281 M
TotalRevenue229000.0250000.0154000.02 M30 M41 M108 M210 M157 M146 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University